Knowledge · Natural Compounds

Iodine

Iodine is an essential trace element; human studies show benefits mainly in correcting an iodine deficiency, for example for the thyroid gland and goitre.

Last updated:

We evaluated 155 human studies on Iodine, including 63 randomised controlled trials and 26 meta-analyses or systematic reviews; the controlled studies include 24,647 participants in total. As of 14 October 2026.

This page as PDF · Summary

1. What Is Iodine? Occurrence, Origin and Forms

Iodine is a halogen and an essential trace element that the body cannot produce itself. It occurs in seaweed, marine fish and iodised table salt, and in the thyroid gland it is a building block of thyroid hormones. Traditionally it is used to prevent iodine deficiency and goitre.

Iodine occurs in seaweed, marine fish, seafood and iodised table salt; in soils and drinking water its distribution varies greatly by region. It is studied as a dietary supplement, as iodised salt and in fortified foods.

Industrially, iodine is obtained from iodine-containing brines and salt deposits, and partly from seaweed. Studies mainly examine potassium iodide, potassium iodate, sodium iodide and molecular iodine, either alone or in fortified foods.

Forms and Preparations Studied

  • Potassium iodide
  • Potassium iodate
  • Sodium iodide
  • Molecular iodine (I₂)
  • Iodised table salt
  • Seaweed and kelp preparations

Not covered on this page:

  • Radioiodine (I-131) in thyroid diagnostics and therapy
  • Iodine-containing skin antiseptics
  • Thyroid hormone preparations such as levothyroxine
  • Iodinated X-ray contrast media and iodine-containing drugs such as amiodarone

2. What Does Iodine Do? Results by Area

AreaResult in controlled studiesStrength of evidenceStudiesParticipants
Children and growthmostly no differencehigh7 meta-analyses · 19 controlled · 20 other5,551
Goitre (struma)mixedhigh1 meta-analyses · 8 controlled · 9 other6,386
Iodised salt and fortification programmesmixedlow1 meta-analyses · 5 controlled · 10 other2,556
Other investigationsmixedhigh14 meta-analyses · 55 controlled · 50 other20,233

How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.

3. What the Studies Show in Detail

Iodine, Children and Growth: Human Studies

In regions with iodine deficiency, iodised table salt was associated with better cognitive development of the children in a randomised study in Ethiopia, growth did not differ 2930. In children with mild iodine deficiency, a controlled study with iodide tablets found better scores in individual cognitive subtests 48, while another controlled study with iodide tablets in pregnant women with mild iodine deficiency saw no difference in the children's IQ 35. The findings apply to iodised table salt, iodide tablets and iodised oil. Combined preparations with other micronutrients cannot be attributed to iodine alone 13. Urinary iodine excretion is a supply parameter, not a clinical effect. Thyroid values are laboratory values, not a clinical effect. Overall, the findings are inconsistent: a benefit is seen mainly in correcting an existing iodine deficiency, not with additional administration to adequately supplied children.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Keats et al. 2021systematic review · 451,723 participantsSingle and multiple micronutrient supplements, including iodine; Pregnancy; vs. Folic acid, iron-folic acid, multiple micronutrients, lipid-based nutrientsLow birthweight (IFA vs. folic acid): improved (average RR 0.88, 95% CI 0.78 to 0.99); Low birthweight (MMN vs. iron ± folic acid): improved (average RR 0.85, 95% CI 0.77 to 0.93)
2 Levie et al. 2019meta-analysis · 6,180 participantsNo supplement; urinary iodine and creatinine measured in pregnancy; Pregnancy, gestational weeks up to 14 relevant; vs. UI/Creat <150 µg/g versus higher valuesChild verbal IQ: no difference (-0.6 point; 95% CI: -1.3 to 0.1 points; P = 0.082); Child nonverbal IQ: no difference (-0.6 point; 95% CI: -1.7 to 0.4 points; P = 0.246)
3 Farebrother et al. 2018systematic review · 5,729 participantsIodine fortification (iodized salt) or iodine supplements, any form/dose; any dose and regimen, not reported individually; vs. Placebo, noniodized salt, or no interventionMean birthweight in severe iodine deficiency: improved (MD: 200 g; 95% CI: 183, 217 g); Primary growth outcomes in other groups: no difference; Insulin-like growth factor-1 in moderate-to-mildly iodine-deficient schoolchildren: improved (MD: 38.48 ng/mL; 95% CI: 6.19, 70.76 ng/mL)
4 Harding et al. 2017systematic review · 2,700 participantsIodine tablets, capsules or drops, sometimes with vitamins/minerals; vs. no iodine supplementationPerinatal mortality: improved (average RR 0.)
5 Velasco et al. 2026systematic review · 2,528 participantsIodine supplementation alone or with iron; 150 µg daily for 28 weeks; single dose 100 mg or 400-490 mg; Follow-up 3 to 22 months; vs. PlaceboCognitive function (validated scales): improved (standardised mean difference 0.19, 95% confidence interval (CI) 0.04 to 0.34); Weight (kg): no difference (mean difference (MD) -0.20, 95% CI -1.92 to 1.52)
7 Walsh et al. 2019systematic review · 1,394 participantsIodine as iodide salt added to enteral or parenteral feeds; vs. Placebo or no supplementationMortality before hospital discharge: no difference (typical RR 1.01, 95% CI 0.72 to 1.42); Bayley-III cognitive composite score at 2 years: no difference (MD -0.30, 95% CI -2.44 to 1.84); Bayley-III motor composite score at 2 years: no difference (MD 0.20, 95% CI -2.15 to 2.55)
16 Daniel et al. 2025systematic reviewNo iodine intervention, observation of iodine status (diet, iodized salt); Studies 2010 to 2024, NHANES data 2011-2020; vs. No intervention control; WHO threshold <150 µg/LOffspring neurodevelopment and IQ with low maternal UIC: worsened (reduced IQ scores)
21 Favara et al. 2024systematic reviewIodine via maternal diet/supplementsNeurodevelopment: improved

Further studies in this area: 23 24 25 29 30 35 37 43 44 45 47 48 53 58 61 62 68 70 82 85 88 93 96 97 104 105 113 114 117 121 122 127 131 139 144 145 146 147

Iodine and Goitre (Struma): Human Studies

In iodine deficiency areas, daily iodine administration in pregnant women slowed the increase in thyroid volume compared with controls 7088. After birth, the volume fell compared with the baseline value 6566. A placebo-controlled study found no confirmed difference in thyroid volume 63. The frequency of goitre fell in Zaire in villages with iodised oil, whether given by mouth or as an injection, while it remained the same in control villages 94. A Cochrane review found a trend towards less goitre with iodised table salt, not significant in all studies 8. In breastfeeding women, the frequency of goitre fell with potassium iodide capsules or iodised salt compared with the baseline value 58. The findings apply to people with existing iodine deficiency; whether additional iodine administration is beneficial when supply is sufficient is therefore not clarified. Algae and kelp preparations as well as multi-ingredient preparations with fluctuating iodine content were not tested as pure iodine and do not allow conclusions of their own.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
5 Velasco et al. 2026systematic review · 2,528 participantsIodine supplementation alone or with iron; 150 µg daily for 28 weeks; single dose 100 mg or 400-490 mg; Follow-up 3 to 22 months; vs. PlaceboGoitre: unclear (RR 0.68, 95% CI 0.15 to 3.07)
8 Wu et al. 2002systematic review · 334 participantsIodised salt; vs. Non-iodised salt, iodised water, iodised oil, potassium iodide vs. potassium iodateGoitre rate: improved
12 Harikrishnan et al. 2026systematic reviewIodine via diet/iodized salt (regions with differing iodine status); vs. Coastal versus inland regionsPrevalence of goiter: improved
58 Gebreegziabher et al. 2019randomised controlled · 106 participantsPotassium iodide capsule vs. iodized salt; 225 µg iodine daily as capsule or iodized salt weekly; 26 weeks; vs. Potassium iodide capsule vs. iodized saltGoiter prevalence: unclear (significantly decreased)
63 Censi et al. 2019randomised controlled · 90 participantspotassium iodide tablets (iodide) versus placebo; 225 µg/day; from enrollment until 8 weeks after delivery; vs. placebo control group (3:2 randomization)thyroid volume (TV): no difference (+Δ7.43% in the Iodine group, and by +Δ11.17% in the Placebo group)
65 Reinhardt et al. 1998randomised controlled · 70 participantspotassium iodide; 50 µg or 250 µg daily; 8 months postpartum, starting 5 days after delivery; vs. 50 µg versus 250 µg; plus untreated group in study Ithyroid volume: unclear (25.4 +/- 1.5 ml (mean +/- sem) to 18.2 +/- 1.25 p <0.001); thyroid volume without iodine: unclear (29 +/- 2.2 ml; at 3 months 27.5 +/- 3.0 ml)
66 Antonangeli et al. 2002randomised controlled · 67 participantsiodide (potassium iodide) daily; 200 µg/day (group A) vs. 50 µg/day (group B); daily up to 6 months after delivery; vs. 200 µg iodide vs. 50 µg iodide dailythyroid volume during gestation: unclear (slight but not significant increase in TV during gestation was observed only in group B); thyroid volume after delivery: unclear (final TV being significantly reduced with respect to the initial volume in group A)
70 Pedersen et al. 1993randomised controlled · 54 participantsiodine supplementation; 200 µg iodine/day; from weeks 17-18 of pregnancy until 12 months after delivery; vs. control group without iodinethyroid size: improved

Further studies in this area: 88 89 94 99 111 112 113 127 135 144

Iodine, Iodised Salt and Fortification Programmes: Human Studies

In regions with iodine deficiency, iodised table salt improved iodine status: a randomised controlled study with over a thousand pregnant women and their children in Ethiopia found less iodine deficiency in mothers and children 30. Another randomised study in Ethiopia advised mothers on the use of iodised salt and found a higher urinary iodine excretion in the children of the intervention group than in the control group 34. Both studies took place in regions with existing iodine deficiency, not with adequate supply. With mixtures, the attribution to iodine alone is limited: salt double-fortified with iodine and folic acid did not change salt intake 41, and a salt fortified four times with iron, iodine, folic acid and vitamin B12 did not differ from salt double-fortified with iron and iodine in acceptance, consumption and sensory distinguishability 64. The strength of evidence is low; the controlled studies are small to medium-sized and largely limited to Ethiopia, while the remaining work mainly describes supply and laboratory values such as urinary iodine excretion and some remained without a control group.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
23 Bath et al. 2022systematic reviewIodine from iodized salt and foods; vs. Intake versus dietary recommendationsNational surveys including iodized salt in estimation: unclear (32% of national surveys (n = 7))
30 Mohammed et al. 2020randomised controlled · 1,220 participantsIodized salt via early market access; from conception to child age 2–13 months; vs. control with later market access to iodized saltIodine deficiency (UIC <50 μg/L) in mothers prepartum: improved (28% vs. 41%, p < .05); Iodine deficiency (UIC <50 μg/L) in children: improved (13% vs. 20%, p < .05)
34 Ferede et al. 2026randomised controlled · 834 participantsIodized table salt (iodide) in households; mean iodide content 45.3 ppm in table salt; 15-month intervention; vs. intervention vs. control group (cluster randomized)iodide content in table salt: unclear (45.3 ppm)
41 Nane et al. 2026randomised controlled · 342 participantsDouble-fortified salt with iodine and folic acid (DFS-IoFA); vs. Salt intake before versus during interventionDiscretionary salt intake: no difference (8.7 ± 4.3 g/d before and 8.8 ± 4.0 g/d during the intervention (P = 0.8))
64 Guetterman et al. 2025randomised controlled · 77 participantsQuadruple-fortified salt (iron, iodine, folic acid, vitamin B12) vs. double-fortified salt vs. iodized salt; 3 weeks (1 week per salt type); vs. Double-fortified salt and iodized saltAcceptability (overall hedonic rating): no difference (QFS: 7.8 (0.7) compared with DFS: 7.7 (1.2); P = 0.68); Weighed household salt use: no difference; Sensory discrimination in triangle tests: no difference
91 Pattisapu et al. 2024controlled · 83 participantsDouble fortified salt (folic acid plus iodine); approximately 300 µg/d folic acid; 4 months; vs. pre-post design, no control groupmedian serum folate: improved (increased from 14.6 (IQR, 11.2-20.6) nmol/L at baseline to 54.4 (IQR, 43.5-54.4) nmol/L)
95 Catumbela et al. 2025cross-sectional study · 2,250 participantsHousehold iodized salt; Adequate iodization 15-40 ppm; vs. Pregnant vs. non-pregnant; provincial strataHouseholds using iodized salt: unclear (74.3%); Households with adequately iodized salt (15-40 ppm): unclear (29.2%)
96 Jamal¹ et al. 2026cross-sectional study · 300 participantsIodized salt (household use); vs. Children with above-average vs. below-average IQMaternal knowledge of iodized salt: improved

Further studies in this area: 99 111 113 114 117 128 140 146

Iodine: Further Outcomes in Studies

In iodine deficiency areas, iodised table salt raised urinary iodine excretion 829. With iodine administration, thyroglobulin was lower or rose less than in the control groups 4854556370. The infants' urinary iodine excretion remained the same under the lower iodine dose given to the mother as under placebo 82, and potassium iodide capsules and iodised salt did not differ in breast milk and urinary iodine in breastfeeding women 85. Urinary iodine excretion fell in one study under a palaeolithic diet that excludes iodised table salt and dairy products, compared with a diet according to the Nordic recommendations 84. The robustness is inconsistent, because the studies examined very different forms — iodide, iodate, molecular iodine, iodised table salt, iodised oil and iodine-rich foods — in some cases small groups and often only over months. Some of the investigations concerned combined preparations with iron, folic acid, zinc or other micronutrients, whose findings cannot be attributed to iodine alone 1910. It remains open how an additional iodine administration affects people who are already adequately supplied and whether the observed laboratory changes also have clinical consequences.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Keats et al. 2021systematic review · 451,723 participantsSingle and multiple micronutrient supplements, including iodine; Pregnancy; vs. Folic acid, iron-folic acid, multiple micronutrients, lipid-based nutrientsMaternal anaemia (IFA vs. folic acid): improved (average risk ratio (RR) 0.52, 95% CI 0.41 to 0.66); Stillbirths (MMN vs. iron ± folic acid): improved (average RR 0.91; 95% CI 0.86)
4 Harding et al. 2017systematic review · 2,700 participantsIodine tablets, capsules or drops, sometimes with vitamins/minerals; vs. no iodine supplementationPostpartum hyperthyroidism: improved (average risk ratio (RR) 0.32; 95% confidence interval (CI) 0.11 to 0.91); Digestive intolerance in pregnancy: worsened (average RR 15.33; 95% CI 2.07 to 113.70); Hypothyroidism in pregnancy: no difference (average RR 1.90; 95% CI 0.57 to 6.38)
5 Velasco et al. 2026systematic review · 2,528 participantsIodine supplementation alone or with iron; 150 µg daily for 28 weeks; single dose 100 mg or 400-490 mg; Follow-up 3 to 22 months; vs. PlaceboHypothyroidism: improved (risk ratio (RR) 0.03, 95% CI 0.00 to 0.23); All-cause mortality in infants: improved (RR 0.32, 95% CI 0.14 to 0.73)
6 Haroon et al. 2026meta-analysis · 2,257 participantsPreoperative iodine solution; vs. Control group without iodine solutionIntraoperative estimated blood loss: no difference (mean difference = -24.6 mL, 95% confidence interval: -56.2, 7.0); Operative time: no difference (mean difference = -2.3 minutes, 95% confidence interval: -10.6, 6.0); Endocrine-related complications: no difference (odds ratio = 0.85, 95% confidence interval: 0.42, 1.74)
8 Wu et al. 2002systematic review · 334 participantsIodised salt; vs. Non-iodised salt, iodised water, iodised oil, potassium iodide vs. potassium iodateUrinary iodine excretion: improved
9 Abe et al. 2016systematic review · 52 participantsMultiple-micronutrient supplement (three or more micronutrients); vs. Placebo or no supplementationMaternal anaemia: improved
10 Lall et al. 2026systematic reviewSalt fortified with iodine and other nutrients; vs. Control groups without fortified saltHemoglobin concentration: improved (0.36 (0.22, 0.50)); Odds of anemia: improved; Odds of iron deficiency anemia: improved
11 Nazeri et al. 2026systematic reviewIodized salt, iodine-containing supplements, iodized oil; vs. No uniform comparison; iodine status or supplementation vs. controlPostpartum depressive symptoms and anhedonia with low iodine intake: worsened; Effect of supplementation/fortification on maternal mood: unclear

Further studies in this area: 12 13 14 15 16 17 18 19 20 22 23 25 26 27 28 29 31 32 33 36 37 38 39 40 43 44 45 46 48 49 50 51 52 54 55 56 57 58 59 60 61 63 65 66 67 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 85 86 87 88 89 90 92 94 95 98 99 100 101 102 103 104 106 107 108 109 110 112 115 116 118 119 120 121 123 124 125 126 127 128 129 130 132 133 134 136 137 138 139 140 141 142 143 144 145 148 149

4. How Is Iodine Dosed? Preparation, Dose and Duration in Studies

The studies predominantly tested oral forms: potassium iodide tablets, potassium iodate, iodised table salt and iodised oil, and in some cases also molecular iodine. Some investigations gave iodine via fortified foods or as part of multinutrient preparations. Algae and kelp preparations have a fluctuating iodine content and were not tested as pure iodine.

Preparation or formDoseDurationStudy
Supplement with myo-inositol, probiotics and micronutrients incl. iodine—up to 12 months27
MMN with 250 µg iodine or SQ-LNS with similar nutrient content250 µg/d iodine (MMN); LNS similar; IFA: 60 mg Fe + 400 µg folic aciduntil childbirth (UIC measured at week 36)28
Iodized salt (early market access)—pregnancy until child age 2–13 months29
Iodized salt via early market access—from conception to child age 2–13 months30
Quintuply-fortified salt (QFS) with iodine, iron, zinc, vitamin B12, folic acid vs standard iodized salt—12 months31
Quintuply-fortified salt (QFS) vs. iodized saltSalt disappearance 6.0 g/adult female equivalent/day; iodine dose not reported12 months (assessments at 0, 6 and 12 months)32
Daily prenatal multiple micronutrient supplement containing iodine vs. iron and folic acid (FeFol)300 µg iodine dailyPregnancy until 30 weeks' gestation; follow-up to 24 weeks postpartum33
Iodized table salt (iodide) in householdsmean iodide content 45.3 ppm in table salt15-month intervention34
200 µg iodine orally once daily as a tablet until delivery vs. placebo200 µg iodine once daily, adherence 87%from enrolment (mean gestational age 10·7 weeks) to delivery; children re-assessed at age 5–6 years35
Oral iodized oil (OIO) vs. poppy-seed oil placebo—First dose at 8 weeks, boosters at 4-week intervals, follow-up at 6 months36
Daily oral iodine 200 µg or placebo until delivery200 µg iodine daily orallyUntil delivery, compliance 88%37
Quintuply-fortified salt (QFS) vs. iodized salt (IS)—12 months38
About 10 g iodized salt daily versus noniodized salt with low-iodine or noniodine dietabout 10 grams of iodized salt dailydietary intervention 24 months; recurrence assessed 12 months after ATD withdrawal39
Iodized salt with 32 ppm iodine, fortified with folic acid7.8 ± 1.8 g salt/day; folic acid 99, 36 or 0 ppm26 weeks, bi-weekly delivery40
Iodized oil (iodine form/dose not reported); plus selenium or placebonot reported12 months42

5. Is Iodine Safe? Side Effects in Studies

In the studies on iodine administration in iodine-deficient areas, predominantly no or only mild, temporary side effects were reported 8636566. In a controlled study with iodide tablets in pregnant women, adverse events occurred with similar frequency in both groups 35.

StudyReported side effects
4 Harding et al. 2017Less postpartum hyperthyroidism, more digestive intolerance in pregnancy
5 Velasco et al. 2026No study reported adverse events related to iodine
6 Haroon et al. 2026Endocrine complications, hypocalcemia, hematoma, recurrent laryngeal nerve injury similar to control
8 Wu et al. 2002No adverse effects observed
9 Abe et al. 2016none reported, no data on adverse effects
11 Nazeri et al. 2026Potential increase in emotional distress under specific conditions (supplementation)
13 Lv et al. 2026not reported
25 Zhou et al. 2013Safety assessed, no specific findings reported
32 Goh et al. 2025not reported
35 Gowachirapant et al. 2017adverse events similar between groups: 24 vs. 28 women (abortion, blighted ovum, intrauterine death)
37 Verhagen et al. 2020Slightly greater decrease in free and total thyroxine in the iodine group (p < 0.05)
40 Tessema et al. 2026No group-wise differences in reported adverse events

6. What Remains Open: Limits of the Evidence

  • The benefit has been shown mainly for correcting an existing iodine deficiency; the effect of additional iodine administration when supply is adequate is open.
  • Many controlled studies are small to medium-sized and predominantly limited to individual regions such as Ethiopia.
  • The studies tested very different iodine forms and preparations, which makes direct comparison difficult.
  • Findings on combination preparations with other micronutrients cannot be attributed to iodine alone.
  • Whether observed changes in laboratory values such as urinary iodine excretion also have clinical consequences remains unclear.

7. Bottom Line: What Is Established About Iodine

Iodine is an essential trace element that the body cannot produce itself, and in the thyroid gland it is a building block of thyroid hormones. Human studies show the clearest benefit in correcting an existing iodine deficiency: in iodine-deficient areas, iodine administration dampened the increase in thyroid volume during pregnancy 7088, and the frequency of goitre decreased in villages with iodised oil 94. Iodised table salt also improved the iodine status of mothers and children 30. In children in iodine-deficient regions, iodised table salt was associated with better cognitive development in a randomised study in Ethiopia, while no difference was found in growth 2930.

The findings apply to the respective form and preparation investigated, especially iodide, iodate, iodised table salt and iodised oil. Algae and kelp preparations as well as multinutrient preparations with fluctuating iodine content do not allow conclusions of their own about pure iodine.

Frequently Asked Questions

How well has Iodine been studied in humans?

We evaluated 155 human studies on Iodine, including 63 randomised controlled trials and 26 meta-analyses or systematic reviews; the controlled studies include 24,647 participants in total. As of 14 October 2026.

Does Iodine help with children and growth? What the studies show

We evaluated 7 meta-analyses or systematic reviews, 19 controlled studies and 20 further studies; the controlled studies include 5,551 participants in total. Result of the controlled studies: mostly no difference. Strength of evidence under our published rules: high. Sources: 1234

Does Iodine help with goitre (struma)? What the studies show

We evaluated one meta-analysis or systematic review, 8 controlled studies and 9 further studies; the controlled studies include 6,386 participants in total. Result of the controlled studies: mixed. Strength of evidence under our published rules: high. Sources: 581258

Does Iodine help with iodised salt and fortification programmes? What the studies show

We evaluated one meta-analysis or systematic review, 5 controlled studies and 10 further studies; the controlled studies include 2,556 participants in total. Result of the controlled studies: mixed. Strength of evidence under our published rules: low. Sources: 23303441

What is iodine studied for in human studies?

The main areas investigated are the correction of iodine deficiency, thyroid volume and the frequency of goitre. In iodine deficiency areas, controlled studies showed that iodine administration had advantages for iodine status, thyroid volume and frequency of goitre 8708894. In addition, iodine status, thyroid hormone levels and urinary iodine excretion were measured as supply and laboratory parameters.

Which iodine forms were tested in the studies?

Predominantly potassium iodide, potassium iodate, iodised table salt and iodised oil were tested, and in some cases also molecular iodine. The forms differ in absorption and effect, so findings apply only to the respective form and preparation investigated. Algae and kelp preparations have a fluctuating iodine content and were not tested as pure iodine.

Does iodine show a benefit when supply is adequate?

That is still open: in a study with breastfeeding mothers in a country with salt iodisation, the infants' urinary iodine excretion remained the same under the lower iodine dose as under placebo 82. The demonstrated benefit mainly concerns correcting an existing iodine deficiency.

How well tolerated was iodine in the studies?

In studies on iodine administration in iodine-deficient areas, predominantly no or only mild, temporary side effects were reported 8636566. In a controlled study with iodide tablets in pregnant women, adverse events occurred with similar frequency in both groups 35.

What should be noted with algae and kelp preparations?

Algae and kelp preparations have a fluctuating iodine content and were not tested as pure iodine.

Sources

  1. 1
  2. 2
    Levie D, Korevaar TIM, Bath SC, Murcia M, Dineva M, Llop S et al. · 2019
  3. 3
    Farebrother J, Naude CE, Nicol L, Sang Z, Yang Z, Jooste PL et al. · 2018
  4. 4
    Harding KB, Peña-Rosas JP, Webster AC, Yap CM, Payne BA, Ota E et al. · 2017
  5. 5
    Velasco I, Rueda-Etxebarria M, Trak-Fellermeier MA, Taylor P, Rabassa Bonet M, Chi Y et al. · 2026
  6. 6
    Haroon AM, Ghani A, Ayesh AR, Witkowiak MM, Alogakos M, Burns J et al. · 2026
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
    Harikrishnan ST, Azeez A, Reji S, Jacob DM, Al Hamdani MS, Eksheir S et al. · 2026
  13. 13
  14. 14
    Aarsland TE, Aakre I, Stea TH, Henjum S, Markhus MW, Strand TA et al. · 2025
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
    Nazeri P, Chashmyazdan M, Masoumi M, Bagheri M, Taghva Nakhjiri M, Shafaatdoost M et al. · 2025
  20. 20
  21. 21
    Favara G, Maugeri A, Barchitta M, Lanza E, Magnano San Lio R, Agodi A · 2024
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
    Gowachirapant S, Jaiswal N, Melse-Boonstra A, Galetti V, Stinca S, Mackenzie I et al. · 2017
  36. 36
    Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine
    Taffs RE, Enterline JC, Rusmil K, Muhilal, Suwardi SS, Rustama D et al. · 1999
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
    Moreno-Reyes R, Mathieu F, Boelaert M, Begaux F, Suetens C, Rivera MT et al. · 2003
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
    van den Briel T, West CE, Bleichrodt N, van de Vijver FJ, Ategbo EA, Hautvast JG · 2000
  48. 48
    Gordon RC, Rose MC, Skeaff SA, Gray AR, Morgan KM, Ruffman T · 2009
  49. 49
    Herter-Aeberli I, Cherkaoui M, El Ansari N, Rohner R, Stinca S, Chabaa L et al. · 2015
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
    Thomson CD, Campbell JM, Miller J, Skeaff SA, Livingstone V · 2009
  60. 60
    Razmandeh R, Abbaspour F, Yazdanpanah L, Shahbazi S, Heidari M, Tabatabaei-Malazy O et al. · 2026
  61. 61
  62. 62
  63. 63
  64. 64
    Guetterman HM, Rajagopalan K, Fox AM, Johnson CB, Fothergill A, George N et al. · 2025
  65. 65
    Efficacy and safety of iodine in the postpartum period in an area of mild iodine deficiency
    Reinhardt W, Kohl S, Hollmann D, Klapp G, Benker G, Reinwein D et al. · 1998
  66. 66
    Antonangeli L, Maccherini D, Cavaliere R, Di Giulio C, Reinhardt B, Pinchera A et al. · 2002
  67. 67
  68. 68
  69. 69
    Iodine therapy for thyroidectomy patients exhibiting high thyroid-stimulating hormone values: a randomised study
    Taylor JD, Radcliffe SN, Basu PK, Atkins P · 1993
  70. 70
    Pedersen KM, Laurberg P, Iversen E, Knudsen PR, Gregersen HE, Rasmussen OS et al. · 1993
  71. 71
  72. 72
    Thyroidectomy: is Lugol's iodine necessary?
    Coyle PJ, Mitchell JE · 1982
  73. 73
  74. 74
    Aakre I, Tveit IB, Myrmel LS, Fjære E, Ballance S, Rosendal-Riise H · 2023
  75. 75
    The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism
    Chang DC, Wheeler MH, Woodcock JP, Curley I, Lazarus JR, Fung H et al. · 1987
  76. 76
  77. 77
  78. 78
  79. 79
    Young AE, Kemp JF, Uhlson C, Westcott JL, Ali SA, Saleem S et al. · 2021
  80. 80
  81. 81
    Moreno-Vega A, Vega-Riveroll L, Ayala T, Peralta G, Torres-Martel JM, Rojas J et al. · 2019
  82. 82
  83. 83
  84. 84
    Manousou S, Stål M, Larsson C, Mellberg C, Lindahl B, Eggertsen R et al. · 2018
  85. 85
  86. 86
    Correlation between Iodine Supplement in Pregnancy and Neonatal TSH Level
    Dandamrongrak P, Chawanpaiboon S · 2016
  87. 87
    Cobra C, Muhilal, Rusmil K, Rustama D, Djatnika, Suwardi SS et al. · 1997
  88. 88
    Glinoer D, De Nayer P, Delange F, Lemone M, Toppet V, Spehl M et al. · 1995
  89. 89
  90. 90
    Iodine replacement in fibrocystic disease of the breast
    Ghent WR, Eskin BA, Low DA, Hill LP · 1993
  91. 91
    Pattisapu JV, Manda VV, Kottakki MNR, Kajana PM, Kancherla V, Bhaganagarapu HR et al. · 2024
  92. 92
  93. 93
  94. 94
  95. 95
    Catumbela E, de Lemos M, Nimi T, Têmbua C, Paixão JP, Kapapelo A et al. · 2025
  96. 96
  97. 97
  98. 98
    Machado A, Gonçalves C, Moreira P, Pinho O, Padrão P, Silva-Santos T et al. · 2023
  99. 99
  100. 100
    Eminoğlu DÖ, Laloglu E, Kasali K, Aydin T, Bulut E, Yaliniz G et al. · 2025
  101. 101
    Urinary iodine excretion in mothers and their breast-fed children in relation to other childhood nutritional parameters
    Akanji AO, Mainasara AS, Akinlade KS · 1996
  102. 102
  103. 103
  104. 104
    Alemu R, Tafere K, Gashu D, Joy E, Bailey E, Lark R et al. · 2025
  105. 105
  106. 106
  107. 107
  108. 108
  109. 109
    Manousou S, Carlsson LMS, Eggertsen R, Hulthén L, Jacobson P, Landin-Wilhelmsen K et al. · 2018
  110. 110
    Mercier F, Bonal M, Fanget F, Maillard L, Laplace N, Peix JL et al. · 2018
  111. 111
  112. 112
  113. 113
    Delić T, Karanović Štambuk S · 2026
  114. 114
    Grossklaus R, Liesenkötter KP, Lawrenz B, Thieme F · 2026
  115. 115
  116. 116
    Milionis C, Koukkou EG, Markou KB, Ilias I · 2026
  117. 117
  118. 118
  119. 119
    López-Sebastiani V, Quiroz-Cornejo KV, Arellano-Salazar MP, Monje-Bolivar F, Samillan VJ · 2026
  120. 120
  121. 121
    Khudair A, Khudair A, Niinuma SA, Habib H, Butler AE · 2025
  122. 122
  123. 123
  124. 124
  125. 125
  126. 126
    Hart KH, Hill AJ, Gonzalez JT, de la Hunty A, Gallagher AM, Stanner SA · 2025
  127. 127
    Moreno-Reyes R, Fuentes Peña C, Nuñez JF, Sánchez MB, Carvajal JJ, Roble K et al. · 2025
  128. 128
  129. 129
    Vergatti A, Abate V, Garofano F, Fiore A, De Filippo G, Strazzullo P et al. · 2025
  130. 130
  131. 131
  132. 132
    Huang L, Huhulea EN, Enwere C, Aifuwa E, Frishman WH, Aronow WS · 2025
  133. 133
    Robinson SR, Trivedi MS, Fayet-Moore F · 2025
  134. 134
  135. 135
  136. 136
    Shulhai AM, Rotondo R, Petraroli M, Patianna V, Predieri B, Iughetti L et al. · 2024
  137. 137
    Carretero-Krug A, Montero-Bravo A, Morais-Moreno C, Puga AM, Samaniego-Vaesken ML, Partearroyo T et al. · 2024
  138. 138
  139. 139
  140. 140
  141. 141
  142. 142
  143. 143
  144. 144
  145. 145
  146. 146
  147. 147
  148. 148
    Negro R, Soldin OP, Obregon MJ, Stagnaro-Green A · 2011
  149. 149

Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.

International Health Research · https://ih-research.com/en/knowledge/iodine/ · Last updated: 2026-10-15